Agenus to Participate in B. Riley Healthcare Conference
Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming B. Riley Virtual Healthcare Conference on January 18th. The fireside chat will take place at 3:00 p.m. ET on January 18th.
To access this event, please RSVP to your B. Riley Securities sales representative. Following the event, a replay of the fireside chat will be posted to the company's website at https://investor.agenusbio.com/events-and-presentations.
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company's mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.
Global Payments Inc. today announced results for the first quarter ended March 31, 2024.
"We are pleased with our solid start to the year, delivering high single-digit adjusted net revenue growth and mid-teens adjusted earnings per share growth in...
Dayforce, Inc. ("Dayforce" or the "Company") , a global leader in human capital management ("HCM") technology, today announced its financial results for the first quarter ended March 31, 2024. "I...
Viatris Inc. , a global healthcare company, recently launched Unmind as part of its global wellbeing program, Elevate. Unmind is a leading provider of workplace mental health solutions designed by psychologists to help individuals understand and be...
MMC Foundation Singapore is excited to announce the launch of Move Move Coin (MMC), the first-of-its-kind blockchain sports project designed to transform how we think about fitness and technology. This pioneering initiative is set to merge health...
In April 2024, EpiSci completed operator training on Starling, a TacticalAI-enabled autonomy product tailored for networked collaborative autonomous platform operation, during multiple test events in partnership with the US Air Force AFWERX Autonomy...